Luca Monzo

Dec 10, 2024 | onlinelibrary.wiley.com | Luca Monzo |Université de Lorraine |Kenneth Dickstein |Emmanuel Bresso

Introduction Although long-term survival after myocardial infarction (MI) has improved over the last four decades, mainly due to reperfusion therapy and evidence-based treatments, ischaemic heart disease remains a leading cause of morbidity and mortality worldwide with a high global disease burden.1-3 In recent years, there has been a plateau in the reduction of mortality rates, particularly among patients with heart failure (HF) after MI that face a particular high risk of adverse events.4,...